melanoma: A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.
| Name | CD2_INSITU_MELANOMA |
|---|---|
| Long name | Melanoma in situ |
| Hospital Discharge registry | ICD-10: D03 |
| Cause of Death registry | ICD-10: D03 |
| Include | CD2_INSITU_MELANOMA_LIP, CD2_INSITU_MELANOMA_EYELID, CD2_INSITU_MELANOMA_EAR, CD2_INSITU_MELANOMA_FACE, CD2_INSITU_MELANOMA_SCALPNECK, CD2_INSITU_MELANOMA_TRUNK, CD2_INSITU_MELANOMA_UPPERLIMB, CD2_INSITU_MELANOMA_LOWERLIMB, CD2_INSITU_MELANOMA_NOS |
| Level in the ICD-hierarchy | 2 |
| First defined in version | DF2 |
| Latin name | Melanoma in situ |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 393 | 205 | 188 |
| Unadjusted prevalence (%) | 0.18 | 0.17 | 0.20 |
| Mean age at first event (years) | 65.78 | 63.21 | 68.59 |
| Case fatality at 5-years (%) | 2.29 | 0.00 | 4.79 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.0 |
| Recurrence at 6 months (%) | 31.30 | 33.66 | 28.72 |
before Melanoma in situ
after Melanoma in situ
Loading survival analyses plot…
Loading survival analyses table…